Clinical trial
A Phase III, Multi-center, 12-month, Open-label Safety Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).
NCT00152035 is registered in ClinicalTrials.gov with Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III, Multi-center, 12-month, Open-label Safety Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).
- Lead sponsor
- Shire
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 10, 2005
- Completion date
- November 7, 2006
- Enrollment
- 505 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.